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Mycobacterial lipids have long been known to modulate the function of a variety of cells of the innate immune
system. Here, we report the extraction and characterisation of polar and apolar free lipids from Mycobacterium bovis
AF 2122/97 and identify the major lipids present in these fractions. Lipids found included trehalose dimycolate
(TDM) and trehalose monomycolate (TMM), the apolar phthiocerol dimycocersates (PDIMs), triacyl glycerol (TAG),
pentacyl trehalose (PAT), phenolic glycolipid (PGL), and mono-mycolyl glycerol (MMG). Polar lipids identified
included glucose monomycolate (GMM), diphosphatidyl glycerol (DPG), phenylethanolamine (PE) and a range of
mono- and di-acylated phosphatidyl inositol mannosides (PIMs). These lipid fractions are capable of altering the
cytokine profile produced by fresh and cultured bovine monocytes as well as monocyte derived dendritic cells.
Significant increases in the production of IL-10, IL-12, MIP-1β, TNFα and IL-6 were seen after exposure of antigen
presenting cells to the polar lipid fraction. Phenotypic characterisation of the cells was performed by flow
cytometry and significant decreases in the expression of MHCII, CD86 and CD1b were found after exposure to the
polar lipid fraction. Polar lipids also significantly increased the levels of CD40 expressed by monocytes and cultured
monocytes but no effect was seen on the constitutively high expression of CD40 on MDDC or on the levels of
CD80 expressed by any of the cells. Finally, the capacity of polar fraction treated cells to stimulate alloreactive
lymphocytes was assessed. Significant reduction in proliferative activity was seen after stimulation of PBMC by polar
fraction treated cultured monocytes whilst no effect was seen after lipid treatment of MDDC. These data
demonstrate that pathogenic mycobacterial polar lipids may significantly hamper the ability of the host APCs to
induce an appropriate immune response to an invading pathogen.Introduction
Bovine tuberculosis (BTB), caused by Mycobacterium
bovis (M. bovis), is a zoonotic disease of significant eco-
nomic, animal and public health burden. Consumption
of raw or unpasteurised animal products and contact
with infected carcasses plays a large role in zoonotic M.
bovis infection of humans in Africa and South America
[1,2]. Yet this is not a problem solely associated with
poverty and less developed countries as evidenced by a
recent report that up to 45% of all TB infected children
in San Diego were caused by M. bovis [3]. The incidence
of BTB in cattle in Great Britain (GB) has undergone
steady and continual increase since 1998 despite the* Correspondence: chris.pirson@ahvla.gsi.gov.uk
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reproduction in any medium, provided the orimplementation of control measures, possibly due to the
presence of a wildlife reservoir [4]. Within GB, BTB has
spread drastically since the Foot & Mouth disease out-
break in 2001 with the annual number of animals
slaughtered rising from a mean of 7116 animals between
1998 and 2001 to an annual mean of 26 277 cases be-
tween 2002 and 2010 inclusive [5].
The first point of contact between M. bovis and its
host is likely to be interaction between receptors of its
sentinel cells of the innate immune system such as
macrophages or dendritic cells (DC) and the surface
expressed molecules of the bacilli, the majority of which
are lipid in nature [6,7]. Recognition of mycobacterial
lipids by macrophages has been demonstrated via the
mannose receptor, complement receptors, scavenger
receptors and CD14 [8-10]. Furthermore, various lipidstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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human macrophages [11]. DC are known to possess and
utilise these same receptors as well as other, structurally
related molecules such as the DC specific C - type lectin
(DC - SIGN) which have also been heavily implicated in
immune recognition of the bacilli [12-14].
Many lipids have been implicated in mycobacterial
virulence which are not found in other bacterial genera.
Lipomannan (LM), lipoarabinomannan (LAM), the
phosphatidylinositol mannosides (PIMs), the cord fac-
tors trehalose mono- and dimycolate (TMM and TDM)
and the phthiocerol dimycocerosates (PDIMs) are all
surface bound mycobacterial lipids capable of modulat-
ing innate immunity [15-17]. Recently, newly identified
lipids, such as monomycolyl glycerol (MMG), have been
shown to modulate host immunity [18] and hyperviru-
lence [19]. However, little data exist which describe the
effect of M. bovis derived lipid on bovine innate cells.
Previously published work usually relies on non - patho-
genic mycobacterial species or makes use of an animal
model rather than the pathogen’s natural host. For ex-
ample, work performed by Hope et al. uses bovine
monocyte-derived DC (MDDC) but these cells are sti-
mulated with a synthetic lipopeptide [20] rather than a
M. bovis-specific lipid antigen. Additionally, although
Reed et al. demonstrated that blockage of synthesis of
the phenolic glycolipid (PGL) correlated with increased
secretion of TNF-α, IL - 6 and IL - 12 by the host, and
removed the “hyperlethal” phenotype displayed by the
bacilli, this was only shown in the murine model [19].
Thus, to assess host immune responses to its natural
pathogen’s lipid constituents, lipids were extracted from
virulent M. bovis AF 2122/97 and used to stimulate vari-
ous bovine innate immune cells isolated from live, TB
free, cattle. Cellular responses were evaluated by measur-
ing cytokine production, alterations in cell surface mole-
cules and induction of T-cell proliferation.
Materials and methods
Preparation of bacterial isolates for lipid extraction
Bacterial isolates were grown in Middlebrooks 7H9
medium as previously described [21].
Briefly, bacterial cells were grown in 100 mL volumes
in rolling culture flasks inoculated with 1 mL of a starting
culture. At mid - log phase, cultures were decanted into
sterile tubes and pelleted before being washed twice in
sterile water. Finally, pellets were resuspended in 5 mL
sterile water and heat killed in a water bath at 80 °C to
90 °C for between 1 and 2 h and finally freeze dried.
Extraction of crude free mycobacterial lipid
The extraction of mycobacterial lipid has been previ-
ously described [22]. Briefly, freeze dried bacterial cells
were suspended in methanolic saline before an equalvolume of petroleum ether was added and the mixture
stirred for 12 to 16 h. Cells were pelleted by centrifuga-
tion (7000 g for 10 min) and the non-aqueous phase
containing the apolar lipids was removed and stored. An
equal amount of petroleum ether was added to the aque-
ous lower phase and the mixture stirred for 2 h before
being centrifuged (7000 g for 10 min) and the non-
aqueous layer removed and pooled with the first. These
non-aqueous petroleum ether extracts were dried using a
rotary evaporator with cold finger condenser and the
lipid transferred to a pre-weighed glass tube in 4 : 1
CHCl3 : CH3OH. Evaporation of the CHCl3 : CH3OH
was achieved using a heating block and N2 gas stream
and the tube weighed to determine the mass of apolar
lipids extracted.
Extraction of polar lipids was performed by adding
CHCl3, CH3OH and 0.3% aqueous NaCl in a 9 : 10 : 3
ratio to the cell pellet. The mixture was stirred for 12 to
16 h before being passed through 2 Whatman # 91 fil-
ters. Once dried, the cells were recovered from the filter
papers and re-extracted twice using a 5 : 10 : 4 mixture
of CHCl3, CH3OH and 0.3% NaCl. After a final filtration
to remove the cells, equal volumes of CHCl3 and 0.3%
NaCl were added and the mixture stirred for one hour,
after which the aqueous phase containing the polar
lipids was removed and dried in a rotary evaporator.
Final polar lipid mass was ascertained as described for
the apolar petroleum ether extracted lipid fraction.
Analysis of lipid fractions by 2D Thin Layer
Chromatography (TLC)
Aluminium backed silica gel 60 F254 TLC plates (Fisher
Scientific, Loughborough, Leics, UK) were cut into ap-
proximately 6 cm squares and 100 μg of lipid extract
was spotted onto the plates using glass micro - capillary
pipettes. Plates were dried thoroughly before being
placed in TLC tanks containing appropriate solvent mix-
tures (systems A - E, Table 1). TLC plates were dried be-
tween each run and before staining to ensure that
residual solvent was removed. Staining was performed
using a 5% solution of molybdophosphoric acid (MPA)
(Sigma Aldrich, Poole, Dorset, UK) in 95% ethanol (Fig-
ure 1). Stains were sprayed onto TLC plates which were
subsequently charred using a hot air gun before being
photographed or scanned. Identification of individual
lipids was performed by comparison with previously
published TLC analysis [23].
Cattle
BTB free cattle between the ages of 6 and 36 months
were obtained from herds within 4 - yearly testing
parishes with no history of a BTB breakdown in the past
4 years. These animals were purchased when around
6 months old and transported to AHVLA. Whilst at
Table 1 Solvent systems for TLC analysis of mycobacterial lipids (adapted from [22]).
Solvent System Run Direction Components Runs Lipids Resolved
A 1 petroleum ether : ethyl acetate (98 : 2) 3 PDIM, TAG, MQ
2 petroleum ether : acetone (98 : 2) 1
B 1 petroleum ether : acetone (92 : 8) 3 AT, FA
2 toluene : acetone (95 : 5) 1
C 1 chloroform : methanol (96 : 4) 1 FA, GLY
2 toluene : acetone (80 : 20) 1
D 1 chloroform : methanol : water (100 : 14 : 0.8) 1 CF, SL, DAT
2 chloroform : acetone : methanol : water (50 : 60: 2.5 : 3) 1
E 1 chloroform : methanol : water (60 : 30 : 6) 1 DPG, PE PI, PIM
2 chloroform : acetic acid : methanol : water (40 : 25 : 3 : 6) 1
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Bovigam IFNγ assay (Prionics AG, Schlieren-Zurich,
Switzerland) and the single intradermal comparative cer-
vical tuberculin test (SICCT).
Isolation of bovine PBMC from whole blood
Whole blood was mixed in equal amounts with sterile
HBSS containing 10 U mL-1 heparin. This mixture was
overlaid onto Histopaque 1077 (Sigma Aldrich) and cen-
trifuged at 800 g for 40 min. The PBMC interface was
removed using a pastette and washed twice in HBSS
containing heparin. Live cells were identified via trypan
blue exclusion and enumerated using a haemocytometer.
Isolation of CD14+ monocytes from bovine PBMC
PBMC were suspended in 80 μL of MACS rinsing buffer
per 107 cells before the addition of 10 μL of MACS anti
- CD14 MicroBeads (Miltenyi Biotec, Bisley, Surrey, UK)
per 107 cells. After a 15 min incubation at +4 °C on a ro-
tator, cells were pelleted and resuspended in 500 μL per
108 cells and passed through MACS LS columns as per
the manufacturer’s instructions.
The CD14+ fraction was counted and cells diluted to
1.5 × 106 mL-1 in cell culture medium (RPMI 1640
containing 25 mM HEPES, 10% FCS, 1% NEAA,
5 × 10-5 mM β2 - mercapto-ethanol, 100 U mL-1 penicil-
lin and 100 μg mL-1 streptomycin [Gibco Life Technolo-
gies, Paisley, UK]).
Generation of bovine cultured monocytes and MDDC
CD14+ monocytes were plated in 1 mL volumes at
1.5 × 106 mL-1 in 24 well plates (Nunc Nunclon, Ros-
kilde, Denmark) before adding either 1000 U mL-1
equine GM-CSF (Kingfisher Biotech, St Paul, MN, USA)
(cultured monocytes) or 1000 U mL-1 equine GM-CSF
and 4 ng mL-1 bovine IL-4 (AbD-Serotec, Kidlington,
Oxon, UK ) (MDDC). Cells were cultured at 37 °C+ 5%
CO2 for 3 days [20], following which they were har-
vested, re-plated at 1.5 × 106 mL-1 in fresh cell culturemedium and the appropriate volume of lipid solution
was added. Cells were cultured for a further 12 to 16 h
before supernatants were collected and cells harvested
for subsequent flow cytometric analysis.
Preparation of lipid antigen suspensions
Suspensions of all lipid antigens were prepared in an
aqueous phase for use in cell culture experiments after
first removing any CHCl3 : CH3OH by evaporation using
an N2 gas stream. Cell culture medium was added to the
dried lipid and the mixture subjected to 2 cycles of heat-
ing at 80 °C and then sonication for 5 min. Apolar and
polar lipids were used to stimulate cells in vitro at
20 μg mL-1 for 12 to 16 h. These conditions were shown
to be optimal in previous experiments (data not shown).
Measurement of cytokine production
Culture supernatants were assayed for cytokine levels
using the MSD multiplex platform (Meso Scale Discov-
ery, Gaithersburg, MD, USA) as previously described
[24,25]. Briefly, supernatants were analysed using a cus-
tom multiplex electrochemiluminescent system which
allows simultaneous detection of IL-1β, IL-6, IL-10,
IL-12, MIP-1β and TNF-α (Meso Scale Discovery).
Multiplex 96 well plates were supplied with target cap-
ture antibodies spotted onto 6 separate carbon electro-
des in each well (anti-bovine TNF-α [Endogen,
Rockford, IL, USA]; anti-bovine IL-10 and anti-bovine
IL-12 [AbD-Serotec]; anti-bovine IL-1β, anti-bovine IL-6
and cross-reactive anti-human MIP-1β [Meso Scale Dis-
covery]). Plates were blocked with MSD assay buffer for
30 min at room temperature before the addition of sam-
ples or standards for 1 h at room temperature. Recom-
binant standard controls (Meso Scale Discovery) were
prepared by serial dilution. After incubation, plates were
washed and combined biotinylated secondary detector
antibodies were added for a further hour. Finally, plates
were washed, loaded with MSD read buffer and analysed
using an MSD Sector Imager 6000.
Figure 1 2D TLC analysis of crude, free lipids extracted from M. bovis AF 2122/97 and stained with MPA. A - D: Apolar fraction analysed
with TLC systems A, B, C and D. E and F: Polar fraction analysed with systems D and E. PDIM - phthiocerol dimycocerosate; MQ - menaquinone;
TAG - triacyl glycerol; PAT - pentacyl trehalose; PGL - phenolic glycolipid; MMG - monomycolyl glycerol; TMM - trehalose monomycolate; TDM -
trehalose dimycolate; GMM - glucose monomycolate; DPG - diphosphatidyl glycerol; PE - phosphatidyl ethanolamine; PIM - phosphatidylinositol
mannosides (integers denote number of mannoside or acyl groups); PI - phosphatidyl inositol; P - phospholipid.
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Cultured cells were suspended in PBS and labelled with
the live / dead indicator ViViD (Invitrogen Life Tech-
nologies, Paisley, UK) before being transferred to a 96well plate and washed using 150 μL MACS rinse buffer.
Cells were stained for 15 min using either anti-bovine
CD14 (ccG33; Institute for Animal Health; 1:50 dilu-
tion), anti-equine MHCII (MCA1085; AbD Serotec; 1:50
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AHVLA; 1:10 dilution), anti-bovine CD80 (IL - A159;
cell supernatant; AHVLA; 1:10 dilution), anti-bovine
CD86 (IL-A190; cell supernatant; AHVLA; 1:10 dilu-
tion), anti-bovine CD1b (CC14; AbD Serotec MCA831G;
1:10 dilution) or an IgG1 isotype control (Av20; Institute
for Animal Health; 1:50 dilution). Labelled cells were
washed using 150 μL MACS rinse buffer and secondary
labelling was performed using a 1:400 dilution of anti-
IgG1 conjugated to R-Phycoerythrin (R-PE) (Invitrogen;
P21129) in 50 μL volumes for 10 min. After incubation,
cells were washed by the addition of 150 μL PBS, pel-
leted and resuspended in 100 μL of 2% paraformalde-
hyde (Cytofix; BD Biosciences, Oxford, Oxon, UK) for at
least 30 min at 4 °C before analysis on a CyAn ADP ana-
lyser. For capture and analysis, initial gating was on sin-
gle, ViViDlo (live) cells into a subsequent small cell/
lymphocyte exclusion gate.
One way mixed lymphocyte reaction
Bovine MDDC and cultured monocytes were prepared
from 1 animal as described above. Following 3 days in
culture, cells were pulsed with lipid antigen overnight
before being enumerated, washed to remove any cyto-
kines and lipid from the media and incubated at 107
cells mL-1 in the presence of Mitomycin C at
100 μg mL-1 for 30 min at 37 °C + 5% CO2. Lipid pulsed,
Mitomycin C treated MDDC or cultured monocytes
were cultured in 1 mL at 37 °C + 5% CO2 at 2 × 10
5 with
1 × 105 PBMC isolated from a second, allogeneic animal.
After 5 days, cells were pulsed overnight with 1 μCi
well-1 of 3H-thymidine before being harvested using a
Harvester 96 Mach III (TomTec Inc, Hamden, CT,
USA). Lymphocyte proliferation was assessed by the
increased cellular incorporation of 3H-thymidine which
was measured using a MicroBeta2 2450 (Perkin Elmer,
Waltham, MA, USA).
Data and statistical analysis
All data representation and statistical analysis was per-
formed using GraphPad Prism version 5.04 and Graph-
Pad InStat version 3.06 (GraphPad Software, La Jolla,
CA, USA). Flow cytometric data was analysed using
repeated measures ANOVA with a Bonferroni multiple
comparisons post test. Cytokine profile analysis was per-
formed using a Friedman non-parametric repeated mea-
sures ANOVA with Dunns multiple comparisons test.
Results
Extraction and analysis of lipid from AF 2122/97
In order to identify individual lipid components within
the polar and apolar fractions, lipids extracted from the
M. bovis reference strain (AF 2122/97) were subjected to
2D TLC analysis using solvent systems of increasingpolarity and subsequently stained with MPA. Analysis of
the apolar fraction using the least polar TLC system
(Figure 1a) identified the presence of phthiocerol dimy-
cocerosates (PDIMs), menaquinone (MQ) and triacyl
glycerol (TAG). System B (Figure 1b) revealed that the
apolar fraction also contained pentacyl trehalose (PAT),
phenolic glycolipids (PGL) and monomycolyl glycerol
(MMG). System C (Figure 1c) allowed further resolution
of both MMG and PGL. The most polar system used to
analyse the apolar fraction (system D, Figure 1d) identi-
fied both trehalose monomycolate (TMM) and dimyco-
late (TDM; cord factor) as well as glucose monomycolate
(GMM).
TLC analysis of the polar lipid fraction using system D
showed the presence of TMM and TDM (Figure 1e)
while the most polar solvent system (E, Figure 1f )
enabled identification of the most polar lipids, which
included diphosphatidyl glycerol (DPG), phosphatidyl
ethanolamine (PE), phosphatidylinositol mannosides
(PIMs, integers denote number of mannoside or acyl
groups), phosphatidyl inositol (PI) and an unknown
phospholipid (P).
Cytokine responses to M. bovis - derived lipids
Innate immune cells are known to produce cytokines in
response to appropriate antigenic stimuli. In order to as-
sess the effect of M. bovis - derived lipids on 3 types of
bovine innate cells (freshly isolated monocytes, cultured
monocytes and MDDC), cytokine production was mea-
sured after stimulation with the lipid fractions (Figure 2).
The cytokines investigated included IL-10, IL-12, TNF-α,
MIP-1β, and IL-6.
Significantly increased IL-10 secretion was seen from
all 3 cell types following stimulation with the polar lipid
fraction (Figure 2a). Strong IL-10 responses were seen
for 3 animals, while only modest increases were noted
for the remaining cattle (Figure 2a). In contrast, little or
no significant increase in IL-10 production was seen fol-
lowing stimulation with the apolar lipid fraction, al-
though apolar lipids induced some IL-10 production by
cultured monocytes and MDDC from 3 animals. All
responses to apolar lipids were by far lower than those
induced by the polar lipid fraction.
IL-12 levels in the culture supernatants were measured
simultaneously and the results are shown in Figure 2b.
Stimulation with the polar lipid fraction induced a large
increase in IL-12 production by MDDC, while lower
responses were also observed from monocyte and cul-
tured monocyte populations. In contrast to the polar
lipids, stimulation with the apolar lipid fraction resulted
in minimal increases in IL-12 production by monocytes,
cultured monocytes or MDDC.
Levels of MIP-1β were also found to be significantly
increased after exposure to the polar lipid fraction with
Figure 2 IL - 10 (A), IL - 12 (B), MIP - 1β (C), TNFα (D) & IL - 6 (E) production by monocytes and cultured cells in response to
stimulation with crude lipid fractions. Points represent mean responses from duplicate wells for each of 7 animals tested. Lines indicate that
cells were derived from the same animal; * 0< 0.05; ** p< 0.01; *** p< 0.001.
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(Figure 2c). Both cultured monocytes and MDDC pro-
duced noticeably more MIP-1β than fresh monocytes,
with MDDC from 6, and cultured monocytes from 3, of
the 7 animals responding strongly (Figure 2c).
Significant increases in TNFα production were also
seen, again in response to the polar lipid fraction
(Figure 2d). While polar lipid treated cultured mono-
cytes from all 7 cattle produced significant levels ofTNFα, considerably more TNFα was produced by
MDDC (Figure 2d). Further, the level of TNFα produc-
tion was similar between fresh and cultured monocytes
(Figure 2d).
The production of IL-6 (Figure 2e) followed a broadly
similar pattern to that of TNFα (Figure 2d) although
statistical significance was not achieved. Fresh mono-
cytes from 2 cattle produced more IL-6 after exposure
to the polar lipids, which also drove increased IL-6
Figure 3 Surface expression of MHCII (A), CD86 (B), CD1b (C) and CD40 (D) on cultured cells and fresh monocytes after exposure to
crude polar and apolar lipid fractions. A single point represents the median fluorescence intensity of the specific stain after subtraction of an
isotype control (ΔMFI) for each of 7 animals tested; ** p< 0.01; *** p< 0.001.
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(Figure 2e). Polar lipid driven IL-6 production by MDDC
was noted in 5 of the 7 animals screened, with one of
these animals producing more IL-6 to the apolar lipid
fraction than the polar. While statistical significance was
not achieved, the levels of IL-6 produced by MDDC are
notably higher than from fresh or cultured monocytes
(Figure 2e).
These data clearly demonstrate that the polar lipid
fraction drives the production of significant amounts of
IL-10, IL-12, MIP-1β and TNFα from all cell types. Fur-
thermore, it is clear that MDDC produced more IL-12,
TNFα and IL-6 than fresh or cultured monocytes and
MIP-1β production is greater from both cultured mono-
cytes and MDDC than in fresh monocytes.
Phenotypic responses to M. bovis - derived lipids
Exposure of bovine antigen presenting cells to the polar
lipid fraction lead to significant increases in the produc-
tion of a variety of cytokines (Figure 2a-e), all of which
can play important roles in directing the subsequent cell
mediated response. In order to further assess the effect
of M. bovis - derived lipids and the local cytokine milieu
on these cells, analysis of the expression of key antigen
presentation related molecules was assessed by flow
cytometry (Figure 3).Stimulation with the polar lipid fraction resulted in a
significant reduction in the cell surface expression of
MHCII on all three cell types (Figure 3a). Furthermore,
MHCII expression was also lower on MDDC following
stimulation with apolar lipids, although this did not
achieve statistical significance (Figure 3a). CD86 expres-
sion was also significantly reduced on all three cell types
following stimulation with the polar lipid fraction
(Figure 3b). While there was a trend for lower CD86 ex-
pression on all three cell types following stimulation
with the apolar lipid fraction, this again did not achieve
statistical significance (Figure 3b). Interestingly, the
lipid-specific antigen presentation molecule CD1b,
which was constitutively expressed on MDDC, was not
present on monocytes or cultured monocytes nor could
it’s expression be modulated in these cell types by myco-
bacterial lipids (Figure 3c). By contrast, MDDC
expressed CD1b constitutively and incubation with the
polar lipid fraction resulted in a significant reduction in
CD1b surface expression (Figure 3c).
Not all cell surface molecules were down-regulated
following treatment with lipids. CD40 expression on
both monocytes and cultured monocytes increased sig-
nificantly following stimulation with the polar lipid frac-
tion (Figure 3d), although no effect was seen on MDDC.
Finally, no significant difference was seen in CD80 levels
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lipid fractions (data not shown).
In summary, these data demonstrate that M. bovis -
derived lipids, and in particular the polar fraction,
downregulate the expression of several key cell surface
molecules involved in antigen presentation.
Consequence of exposure to M. bovis - derived lipids
To identify and assess any functional consequence of the
lipid induced reduction in molecules related to antigen
presentation the ability of lipid treated innate cell types
to stimulate an alloreactive response was assessed. Co-
culture of the responder PBMC population with either
untreated MDDC or cultured monocytes resulted in a 5
- fold increase in their proliferation (Figure 4). No prolif-
eration was noted for either MDDC or cultured mono-
cytes in the absence of responder cells (data not shown).
Polar lipid treated MDDC retained their ability to induce
proliferation in the responder population despite the
downregulation of important costimulatory molecules.
In contrast, allo - stimulation of the responder popula-
tion by polar lipid treated cultured monocytes resulted
in significantly reduced proliferative responses to levels
comparable with the unstimulated responder control
cells (Figure 4).
Discussion
Mycobacterial lipids have long been implicated in the
interaction between the pathogen and its host. Here we
describe the consequence of exposure to lipids derived
from a virulent M. bovis on the innate immune cells of
cattle.Figure 4 Proliferative responses (in counts per minute [CPM]) of 1 × 1
bars) or polar lipid treated (red bars) MDDC or cultured monocytes. B
*** p< 0.001.Extraction of mycobacterial lipids and their subse-
quent analysis by 2D TLC has been previously described
[22], but little data exists on total lipid profiling of M.
bovis. Previous work by Dandapat et al. [26] attempted
to characterise M. bovis based on the expression of PGL
and PDIMs, but only as a tool for identification of the
organism. In Figure 1, we have applied a complete range
of TLC analyses to polar and apolar lipid extracts which
has allowed the identification of a broad range of charac-
teristic mycobacterial lipids including PDIMS
(Figure 1a), the M. bovis characteristic PGL [27] (figure 1
B-C), TDM (Figure 1d-e) and PIMs (Figure 1f ). As
expected, no sulphoglycolipid was found (Figure 1d).
Interestingly, TDM was found in both the polar and
apolar extracts (Figure 1d-e). This may be related to it’s
particularly amphipathic nature [28] and variable acyl-
ation states which are known to alter both immunogen-
icity and hydrophobicity [29,30] and may cause the
molecule to split differentially across the biphase inter-
face during lipid extraction.
To discover if the lipid fractions were capable of medi-
ating responses of bovine innate immune cells, stimula-
tion experiments were performed and the level of a
range of cytokines was analysed. Significant increases in
the production of various cytokines were measured only
after cells were exposed to the polar lipid fraction. Per-
haps most striking is the significant increase in the pro-
duction of the Th-1 polarising IL-12 and the anti-
inflammatory cytokine IL-10 (Figure 2a-b). While this
may seem contradictory, it is important to note that the
fractions used are complex mixtures of a variety of lipids
some of which are known to induce potent05 PBMC after allotypic stimulation with either untreated (grey
ars represent the mean of triplicate wells ± standard error of the mean;
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[18] and others, such as glycerol monomycolate
(GroMM) are known Th2 polarisers [31].
Little evidence exists on cytokine production by anti-
gen presenting cells after treatment with lipids, however
many lipids have been assessed in the context of both
CD4+ and CD8+ T cells. For example, TDM, which is
present in the polar and apolar fractions (Figure 1d-e),
has been shown to induce both Th1 and Th2 cytokines.
The induction of IFNγ and IL-12 and the depletion of
IL-4 producing NK cells has been attributed to TDM
[32,33] as well as a role, along with IL-6 and TNFα, in
stable granuloma formation [34]. Yet TDM is also impli-
cated in the production of IL-5 and IL-10 in a CD1
dependent manner [35]. Furthermore, GroMM has been
implicated in the induction of Th2 polarising responses
[31] where as the closely related GMM has been shown
to induce Th1 cytokine responses in T cells [36]. Anti-
inflammatory effects have also been attributed to PIM2
and PIM6 where, upon lipid treatment of LPS activated
macrophages, Doz et al. measured downregulation of
TLR4, TNFα, IL-12p40, IL-6, KC and IL-10 as well as
MyD88 mediated NO release [37].
Given the significant increase in IL-10 production by
all innate cell types assessed, and the important role
these cells play in generating and directing the im-
mune response, we analysed the expression of antigen
presentation associated cell surface molecules after
lipid exposure. Lipid treatment of APCs leads to a sig-
nificant decrease in the levels of costimulatory mole-
cules associated with antigen presentation including
MHCII and CD86 on all cell types studied and CD1b
on MDDC (Figure 3a-c). Negative regulation of these
molecules by a variety of lipid components has been
noted previously, especially MHCII in human and
murine systems. Similar to the data presented here, the
19-kDa lipoprotein is capable of downregulating
MHCII expression on human THP-1 macrophages by
inhibiting activation of the IFNγ - induced CIITA
[38,39]. Downregulation of MHCII, as well as TLR2
and TLR4, has also been reported on human MDDC
after lipid exposure [40] and a further study also found
impaired expression of CD1a, MHCII, CD80 and CD83
on human MDDC [41].
Downregulation of CD1 molecules has also been
shown through the discovery that MDDC generated
from BCG treated monocytes did not express CD1 and
showed reduced MHCII, CD40 and CD80 [42] and this
has since been shown to be due to cell wall associated
carbohydrate α-glucan [43] and mediated through the
p38 MAPK pathway [44]. However these experiments
have all been performed in human or murine systems
and with specific lipids, often from avirulent bacterial
isolates.Interestingly, treatment of fresh and cultured mono-
cytes with the polar lipid fraction significantly increased
the level of CD40 expression (Figure 3d) and this effect
is not seen on MDDC. This finding seems contradictory
to the published literature [42,45] however these studies
used BCG or TDM alone, rather than the complex and
more biologically representative lipid preparations
derived from virulent mycobacteria used here, as well as
being performed in human or murine macrophage mod-
els. Bovine MDDC expression of CD40 does not alter
after stimulation with either polar or apolar lipids which
may be due to its constitutively higher levels of expres-
sion than on fresh or cultured monocytes.
Finally, no difference was seen in the expression of
CD80 after lipid treatment, although this has also been
reported in other systems using virulent M. tuberculosis
or avirulent BCG derived lipids [41,42,45].
The significant loss of MHCII, CD86 and CD1b is
consistent with the phenotype of an impaired antigen
presenting cell [46]. Given the effect of the polar lipids
on the expression of these molecules and the concurrent
increase in IL-10 production, we hypothesised that the
polar lipid fraction, or one of its components, hampers
the ability of the cells to successfully present antigen to
T cells and may be able to suppress the induction of a
Th1 response during infection. To assess any functional
deficit in these cells, especially due to the loss in MHCII,
lipid treated and untreated cells were used to drive allo-
typic proliferative responses.
Cultured monocytes drove proliferation of allogeneic
PBMC (Figure 4) and treatment of cultured monocytes
with the polar lipid fraction significantly abrogated
these responses as suggested by the downregulation of
MHCII and other costimulatory molecules. Proliferative
responses were also seen when allogeneic PBMC were
combined with untreated MDDC (Figure 4) however no
difference in proliferation was seen using lipid treated
MDDC despite flow cytometric analysis revealing charac-
teristic reduction in the level of MHCII on the MDDC
(data not shown). While these results seem at odds with
each other, it is possible that the loss of MHCII may be
overcome by the high level of CD40 expressed by MDDC
(Figure 3d) or the constitutively higher levels of IL-12
produced by these cells which further increases signifi-
cantly after lipid stimulation (Figure 2b). Also, some evi-
dence exists that the presence of CD80 is enough to
stimulate allogeneic T cells in the absence of CD86 sig-
nalling [47]. Given the significant reduction in CD86 ex-
pression on MDDC, the maintenance of CD80 may play
a role. Finally, it is possible that, due to constitutively
higher levels of MHCII and CD40 present on MDDC, as
well as their expression of CD1b, the levels of MHCII
and CD86 on these cells remains sufficient to drive an
allotypic reaction.
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fractions are capable of stimulating responses in bovine
innate cells and that these different cell types respond in
distinct ways.
Interestingly, the alteration in cell surface phenotype
of both cultured monocytes and MDDC seen after polar
lipid stimulation is also evident after exposure to the
apolar lipid fraction, albeit to a lesser, not statistically
significant, extent. This may be due to specific lipid
components present in both the polar fraction and the
apolar preparation, such as TDM. However, it may also
be due to the insolubility of less polar lipids in the aque-
ous environment an in vitro culture system which may
limit lipid bioavailability.
In conclusion, we present here the first data to dem-
onstrate the regulatory effects of M. bovis - derived
lipids on bovine innate cells. These lipids, especially
those contained within the polar fraction are capable of
interacting with the host’s innate immune cell’s such that
the cells ability to initiate an adequate T cell response
may be compromised, although this effect could only be
demonstrated for cultured monocytes and not MDDC.
The lipid fractions used in this study contain the total
free extractable lipid from M. bovis AF 2122/97, hence
we were not able to attribute these effects to any specific
lipid entities. However work is currently being under-
taken in our laboratory to further define these responses
and identity the lipids which are responsible for mediat-
ing the effects we have shown. Nevertheless, the effects
mediated by these lipids may play a pivotal role in the
outcome of infection and aid further identification of in-
dividual lipid components responsible for the immuno-
modulatory effects as well as new targets for attenuation
and novel vaccine candidates and adjuvant preparations.
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